Regulatory

Collaboration Press Release

Resistell Announces Start Of Performance Evaluation Study

Resistell has started the Performance Evaluation Study (PES) of its groundbreaking nanomotion technology at Lausanne [...]

15
Jun

Awarenesss

A day to reimagine a better future for every child

The World Conference for the Well-being of Children in Geneva, Switzerland, proclaimed June 1 to [...]

01
Jun

Funding Innovation

Major Milestone For Our Portfolio Company Inura Medical, Who Closes Their Pre-series A Financing Round

Inura Medical's mission is to improve women’s health through the development of an urethral ovulum [...]

20
May

Funding Innovation

Our portfolio company HexagonFab secures CHF 2.5m seed funding to speed discovery and production of the next-gen of biopharmaceuticals!

HexagonFab, a spin-out from the University of Cambridge, has developed a novel approach for drug [...]

06
May

Collaboration Innovation Press Release

Hemex and youEngineering announce strategic partnership

We’re thrilled to announce an exciting new partnership between HEMEX and YouEngineering, a software engineering [...]

14
Apr

Clinical Development, Collaboration, Innovation, Regulatory

Welcome Hi-D Imaging!

Posted on April 11, 2020November 9, 2020 by Franziska Stemmler

11
Apr

We are delighted to welcome Hi-D Imaging AG to our growing list of portfolio companies and are pleased to support them as a strategic clinical and regulatory development partner. Hi-D Imaging AG, an ETH Spin-off medtech company founded in July 2019, aims to revolutionize the cardiovascular sector by making personalized aortic heart valve replacement therapy […]

Continue reading →

Approvals, Funding, Innovation, Regulatory

“Spread the App, not the Virus”

Posted on March 27, 2020November 9, 2020 by Franziska Stemmler

27
Mar

How geoHealthApp can help stop the spread of COVID-19 Friday 27th of March 2020 – GeoHealthApp GmbH, today launched a Betaversion in Germany, Switzerland, Austria, UK and USA that has the potential to help stop the spread of COVID-19! How does it work? People first install the app, and the phone starts recording their location […]

Continue reading →

LK-01 Granted Orphan Drug Designation by the U.S. FDA for Acute Myeloid Leukemia

Posted on June 7, 2018February 18, 2020 by Pascal Winnen

07
Jun

BARCELONA, Spain – Leukos Biotech, a spin-off company founded by the Barcelona based Jose Carreras Leukaemia Research Institute and supported by VCF Inveready, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) for LK-01, a product based on Apomorphine, for the treatment of Acute Myeloid Leukemia. Acute Myeloid Leukaemia (AML) is […]

Continue reading →